Researcher
Chris Verslype
- Disciplines:Oncology
Affiliations
- Digestive Oncology (Division)
Member
From1 Aug 2022 → Today - Clinical Digestive Oncology (Division)
Member
From22 May 2017 → Today - Hepatology (Division)
Member
From1 Oct 2002 → 21 May 2017
Projects
11 - 14 of 14
- Pancreatic cancer: identifying key drivers and drug testing in a clinically relevant model, based on tumor biologyFrom1 Oct 2016 → 30 Sep 2021Funding: FWO fellowships
- The role of conserved genetic and epigenetic responses in hypoxiainduced EMT unraveled via the invertebrate model Daphnia.From1 Oct 2015 → 30 Sep 2019Funding: FWO fellowships
- Identification of candidate biomarkers of intrinsic and acquired resistance to anti-angiogenic agents in metastatic colorectal cancer.From1 Jan 2013 → 31 Dec 2014Funding: Private funding of national origin - undefined
- Evaluation of molecular, dosimetric and ultrastructural imaging in the management of neuroendocrine tumors with Peptide Receptor Radionuclide Therapy: results of a prospective, monocentric, non-controlled phase II studyFrom1 Nov 2008 → 27 May 2015Funding: Nonprofit institution or equivalents
Publications
1 - 10 of 303
- Mendez-Blanco et al. Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells (vol 15, 1984, 2019)(2023)
Authors: Jos van Pelt, Chris Verslype
- Genotype specific and microbiome effects of hypoxia in the model organism Daphnia magna(2023)
Authors: Manon Coone, Karen Bisschop, Chris Verslype, Ellen Decaestecker
Pages: 1669 - 1683 - PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma(2023)
Authors: Sarah Cappuyns, Bram Boeckx, Ingrid Arijs, Aurelie Mechels, Baki Topal, Chris Verslype, Diether Lambrechts, Jeroen Dekervel
- Prognostic role of radiomics-based body composition analysis for the 1-year survival for hepatocellular carcinoma patients(2023)
Authors: Vincent Vandecaveye, Chris Verslype
- Hepatitis B virus (HBV)-related outcomes in patients (pts) with baseline HBV infection in the KEYNOTE-966 study of pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC)(2023)
Authors: Chris Verslype
Pages: S218 - S218 - The ongoing search for biomarkers of response to systemic therapy in advanced hepatocellular carcinoma.(2023)
Authors: Sarah Cappuyns, Jeroen Dekervel, Eric Van Cutsem, Chris Verslype, Diether Lambrechts
- Rituximab and improved nodular regenerative hyperplasia-associated non-cirrhotic liver disease in common variable immunodeficiency: a case report and literature study(2023)
Authors: Willem Roosens, Stephanie Humblet-Baron, Isabelle Meyts, Chris Verslype, Hannah van Malenstein, Schalk Van der Merwe, Wim Laleman, Rik Schrijvers
- Robotic Versus Laparoscopic Hepatectomy: A Single Surgeon Experience of 629 Consecutive Minimally Invasive Liver Resections(2023)
Authors: Chris Verslype
Pages: 2241 - 2249 - Impact on clinical management when using [18F]AlFNOTA-octreotide instead of [68Ga]Ga-DOTA-SSA PET/CT in neuroendocrine tumor patients: preliminary results(2023)
Authors: Jeroen Dekervel, Frederik Cleeren, Michel Koole, Guy Bormans, Chris Verslype, Christophe Deroose
Pages: S508 - S508 - Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study(2023)
Authors: Chris Verslype, Tania Roskams, Sabine Tejpar, Isabelle Vanden Bempt, Jeroen Dekervel
Pages: 9173 - 9181